Elsevier

Annals of Oncology

Volume 31, Supplement 4, September 2020, Page S1155
Annals of Oncology

Genitourinary tumours, non-prostate
LBA23 Pembrolizumab (P) combined with chemotherapy (C) vs C alone as first-line (1L) therapy for advanced urothelial carcinoma (UC): KEYNOTE-361

https://doi.org/10.1016/j.annonc.2020.08.2252Get rights and content
Under an Elsevier user license
open archive

Cited by (0)